Amitabha Mazumder is an Oncology physician affiliated with Oncology Institute of Hope and Innovation. OpenAlex indexes 188 publications with 7,448 citations (h-index 37); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11480 Brookshire Ave Ste 309
Downey, CA 90241
Telephone
562-869-1201Registry record last updated 14 Aug 2018.
Clinical trials
- Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy
Sponsor: NYU Langone Health
- Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
79 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202511 payments
- Novartis Pharmaceuticals CorporationProgram year202518 payments
- AstraZeneca Pharmaceuticals LPProgram year202517 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1985–1990 per NIH RePORTER. The latest:
- PHASE IB TRIAL OF MONOCLONAL ANTIBODY LYMA 1-N &IL-2
University of Southern California
FY1990N01CM047675 - IMMUNOTHERAPY OF CANCER BY LYMPHOKINE-ACTIVATED CELLS
University of Southern California
FY1989K04CA001222 - PHASE IB TRIAL OF MONOCLONAL ANTIBODY LYMA 1-N &IL-2
University of Southern California
FY1989N01CM047675
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Journal of Clinical Oncology
2020 - American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Biology of Blood and Marrow Transplantation
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”